Provided by Tiger Fintech (Singapore) Pte. Ltd.

Salarius Pharmaceuticals Inc

0.9500
-0.0109-1.13%
Post-market: 0.9150-0.0350-3.68%18:00 EDT
Volume:56.15K
Turnover:52.68K
Market Cap:1.66M
PE:-0.14
High:0.9609
Open:0.9400
Low:0.9250
Close:0.9609
Loading ...

Salarius Pharmaceuticals 2024 EPS $(5.79) vs $(30.74) YoY

Benzinga
·
24 Mar

Press Release: Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update

Dow Jones
·
24 Mar

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-Initiated Phase 1/2 Clinical Trial Using Seclidemstat With Azacitidine to Treat Hematologic Cancers

THOMSON REUTERS
·
03 Feb

Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

GlobeNewswire
·
03 Feb

Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge

Benzinga
·
14 Jan

Top Midday Gainers

MT Newswires Live
·
14 Jan

Salarius Pharma Shares More than Double on Merger Deal With Decoy Therapeutics

MT Newswires Live
·
14 Jan

BRIEF-Salarius Pharmaceuticals And Decoy Therapeutics Announce Definitive Merger Agreement

Reuters
·
13 Jan

Salarius Pharmaceuticals to Merge with Decoy Therapeutics

Dow Jones
·
13 Jan

Salarius Pharmaceuticals Inc - New Board to Include Rick Pierce, Barbara Hibner, and Three Independent Directors

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Combined Company to Be Led by Decoy's Co-Founders

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Newly Formed Company to Be Named Decoy Therapeutics

THOMSON REUTERS
·
13 Jan

Salarius Pharmaceuticals Inc - Decoy Investors to Own 86% of Merged Company, Salarius Stockholders 14%

THOMSON REUTERS
·
13 Jan

Press Release: Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement

Dow Jones
·
13 Jan

BRIEF-Salarius Pharmaceuticals Enters Securities Purchase Agreement

Reuters
·
13 Dec 2024